Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 97 | 17.5% |
| Current Price (01/18) | $129.07 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 1,885.7 | |||
| Sales Growth Forecast | 13.0% | |||
| Net Profit Margin | 48.6% | |||
| Projected Shares Outstanding | 64.06 | |||
| EPS - Five year Forecast | $26.33 | |||
| Average P/E Ratio | 11.0 | |||
| Projected Average Price | $289.62 | |||
| Price Appreciation (Annualized) | 17.5% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 17.5% | |||
| Quality | ||||
| Financial Strength | 88 | 21.9 | ||
| EPS Stability | 92 | 23.0 | ||
| Industry Sales Growth Rate | 16.0% | 10.1 | ||
| Industry Net Profit Margin | 25.5% | 23.8 | ||
| Calculated Quality Rating | 78.8 | |||
| Fool CAPS | ||||
Total Players
309
Outperforms
68
Underperforms
All-Stars (79)
64
Outperforms (81%)
15
Underperforms
|
||||
| Fundamental Data Updated: 12/07/2018 | ||||